Related Experiment Video

Updated: Oct 20, 2026

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
07:25

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on: March 6, 2018

A unifying model to explain the increased incidence and higher mortality of prostate cancer in black men

J E Montie1, K J Pienta

  • 1Department of Surgery, University of Michigan, Ann Arbor, 48109-0330, USA.

Urology
|June 15, 1999
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Pre-clinical Orthotopic Murine Model of Human Prostate Cancer
07:01

Pre-clinical Orthotopic Murine Model of Human Prostate Cancer

Published on: August 29, 2016

Related Experiment Videos

Last Updated: Oct 20, 2026

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
07:25

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on: March 6, 2018

Pre-clinical Orthotopic Murine Model of Human Prostate Cancer
07:01

Pre-clinical Orthotopic Murine Model of Human Prostate Cancer

Published on: August 29, 2016

Related Concept Videos

Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Cancer Survival Analysis01:21

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...

Articles linked to this work by shared authors, journal, and citation graph.

Developing a Patient-Centered Model of Prostate Cancer Care: Patient Satisfaction With a Survivorship Program Embedded in Urologic-Oncologic Care.

Urology·2021

Cancer recurrence and lethality are enabled by enhanced survival and reversible cell cycle arrest of polyaneuploid cells.

Proceedings of the National Academy of Sciences of the United States of America·2021

Cancer cells employ an evolutionarily conserved polyploidization program to resist therapy.

Seminars in cancer biology·2020

Multidisciplinary total eradication therapy (TET) in men with newly diagnosed oligometastatic prostate cancer.

Medical oncology (Northwood, London, England)·2020

PET imaging of prostate-specific membrane antigen in prostate cancer: current state of the art and future challenges.

Prostate cancer and prostatic diseases·2016

Variation in the use of postoperative radiotherapy among high-risk patients following radical prostatectomy.

Prostate cancer and prostatic diseases·2016

Temporal trends of treatment and mortality in small renal masses <2cm.

Urology·2026

Preoperative Patient Communication Method and Its Impact on Post Operative Outcomes and Healthcare Utilization Following Cystectomy.

Urology·2026

Prospective feasibility study of cryobiopsy in patients with suspected upper tract urothelial carcinoma.

Urology·2026

Feasibility of AI-Based Automated Identification of Sacral Anatomy and Lead Features During Sacral Neuromodulation Procedures.

Urology·2026

A Contemporary Analysis of Positive Surgical Margin Length and Oncologic Outcomes After Radical Prostatectomy: Results from an Institutional Registry with Long-Term Follow Up.

Urology·2026

Diet quality and prognosis in patients with non-muscle invasive bladder cancer: the Be-Well Study.

Urology·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us